DES the year in review: controversies

Area of Science:

• Interventional Cardiology
• Biomedical Engineering
• Cardiovascular Research

Background:

• Drug-eluting stents (DES) have revolutionized cardiology, demonstrating high efficacy.
• Early DES versions raised safety concerns, necessitating the development of newer coronary stent technologies.
• Despite widespread adoption of new DES, their clinical outcome improvements and expanded indications remain subjects of ongoing debate.

Purpose of the Study:

• To critically evaluate the clinical outcomes and safety profile of contemporary drug-eluting stents.
• To assess whether advancements in DES technology justify their use in patient and lesion subgroups previously managed by cardiac surgery.
• To address outstanding questions regarding the real-world benefits and expanded role of percutaneous coronary intervention (PCI) with modern DES.

Main Methods:

• Systematic review of clinical trials and observational studies on drug-eluting stents.
• Analysis of safety and efficacy data comparing different generations of DES.
• Evaluation of studies investigating the expansion of PCI indications with DES.

Main Results:

• While efficacy is generally high, specific safety concerns associated with early DES have been largely mitigated by newer designs.
• Contemporary DES demonstrate improved safety profiles and sustained efficacy, supporting their role in complex coronary artery disease.
• Evidence suggests PCI with advanced DES is increasingly feasible in patient and lesion subsets traditionally treated surgically.

Conclusions:

• Modern drug-eluting stents offer significant advancements in safety and efficacy over earlier models.
• The improved performance of current DES supports the expansion of percutaneous coronary intervention (PCI) to a broader range of complex coronary anatomies.
• Further research is warranted to fully elucidate the long-term benefits and optimal patient selection for advanced DES in interventional cardiology.